Skip to main content

Table 2 Cycle parameters and reproductive outcomes of repeated cycles between mLP and non-mLP groups

From: The effect of letrozole overlapped with gonadotropin on IVF outcomes in women with DOR or aged over 40 years old with repeated cycles

Group

MLP group

Non-mLP group

P

Number

50

50

 

Cycle parameters

Total Gn dose (IU)

2443.00 ± 97.09

2521.00 ± 157.83

0.548

Days of Gn stimulation (days)

8.30 ± 0.32

10.26 ± 0.44

< 0.01

Features of trigger day

FSH (IU/L)

33.16(24.84–39.92)

23.69(10.04–30.66)

< 0.01

LH (IU/L)

3.92(2.34–5.48)

2.46(1.45–6.38)

0.039

E2 (ng/L)

436.50(278.25–819.50)

1179.00(595.50-1750.75)

< 0.01

Number of follicles ≥ 18 mm

1.80 ± 0.17

1.50 ± 0.17

0.133

Endometrial thickness (mm)

9.73 ± 0.36

10.35 ± 0.40

0.034

IVF laboratory parameters

Number of oocytes retrieved

4.16 ± 0.38

4.88 ± 0.70

0.860

Number of MII oocytes

3.42 ± 2.47

3.56 ± 2.34

0.724

MII oocytes retrieved rate (%)

82.21(171/208)

82.03(178/217)

0.961

Number of fertilized oocytes

2.70 ± 2.24

3.30 ± 2.27

0.092

Fertilization rate (%)

64.90(135/208)

76.04(165/217)

0.012

Normal fertilization rate (%)

70.37(95/135)

84.85(140/165)

< 0.01

Number of cleaved embryos

3.04 ± 2.48

3.22 ± 2.17

0.617

Available embryos rate (%)

62.91(95/151)

50.35(72/143)

0.03

Top-quality embryo rate (%)

47.38(45/95)

38.89(28/72)

0.075

Pregnancy outcomes

Clinical pregnancy rate (%)

37.21 (16/43)

6.06 (4/66)

< 0.001

Miscarriage rate (%)

18.75 (3/16)

75.00 (3/4)

0.061

Live birth rate (%)

30.23 (13/43)

0

< 0.001

  1. Note: MLP: modified letrozole protocol; Gn: gonadotropin; FSH: follicle stimulating hormone; LH: luteinizing hormone; E2: estradiol; T: testosterone; MII oocytes: metaphase II oocytes